Cargando…
Evaluation of (99m)Tc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
Using conventional imaging modalities, it is difficult to detect recurrent lesions in prostate cancer patients who have undergone biochemical relapse, especially in patients with low prostate-specific antigen (PSA) levels. We retrospectively reviewed the files of fifty patients with histopathologica...
Autores principales: | Su, Heng-Chuan, Zhu, Yao, Ling, Guo-Wen, Hu, Si-Long, Xu, Xiao-Ping, Dai, Bo, Ye, Ding-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427779/ https://www.ncbi.nlm.nih.gov/pubmed/27976632 http://dx.doi.org/10.4103/1008-682X.192638 |
Ejemplares similares
-
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
por: Liepe, Knut, et al.
Publicado: (2022) -
[(99cm)Tc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
por: Werner, P., et al.
Publicado: (2020) -
Direct comparison of (99m)Tc-PSMA SPECT/CT and (68)Ga-PSMA PET/CT in patients with prostate cancer
por: Albalooshi, Batool, et al.
Publicado: (2020) -
Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
por: Li, Bo, et al.
Publicado: (2022) -
[(99m)Tc]Tc-PSMA-T4—Novel SPECT Tracer for Metastatic PCa: From Bench to Clinic
por: Maurin, Michał, et al.
Publicado: (2022)